Synapse - Works

Results (4760)

Correlation of response with overall survival (OS) for nivolumab vs everolimus in advanced renal cell carcinoma (aRCC): Results from the phase III CheckMate 025 study

Meeting Abstract

Motzer, R. J.; Sharma, P.; Escudier, B. J.; McDermott, D. F.; George, S.; Srinivas, S.; Tykodi, S. S.; Sosman, J. A.; Plimack, E. R.; Nathan, P. D.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Correlation of PIK3CA mutations in cell-ree DNA (cfDNA) and efficacy of everolimus (EVE in metastatic breast cancer: Results from BOLERO-2

Meeting Abstract

Moynahan, M. E.; Sung, P.; Chen, D.; He, W.; Samoila, A.; You, D.; Bhatt, T.; Patel, P.; Ringeisen, F. P.; Hortobagyi, G. N.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Efficacy of sorafenib in patients with desmoid-type fibromatosis

Meeting Abstract

Munhor, R. R.; Lefkowitz, R. A.; Kuk, D.; Dickson, M. A.; D'Angelo, S. P.; Keohan, M. L.; Chi, P.; Crago, A. M.; Maki, R. G.; Schwartz, G. K.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

IMGN853 (mirvetuximab soravtansine), a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC): Single-agent activity in platinum resistant epithelial ovarian cancer (EOC) patients (pts)

Meeting Abstract

Moore, K. N.; Martin, L. P.; Matulonis, U. A.; Konner, J. A.; Seward, S. M.; Bauer, T. M.; O'Malley, D. M.; Perez, R. P.; Jeong, W. D.; Zhou, Y. H.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

The PRONTO amyloidosis study: A randomized, double-blind, placebo-controlled, global, phase 2b study of NEOD001 in previously treated subjects with light chain amyloidosis and persistent cardiac dysfunction

Meeting Abstract

Merlini, G.; Liedtke, M.; Landau, H. J.; Comenzo, R. L.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Schonland, S.; Guthrie, S. D.; Walling, J.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with paclitaxel (P) in patients (pts) with 1st- to 3rd-line metastatic HER2-negative breast cancer (BC)

Meeting Abstract

Mita, M. M.; Becerra, C.; Richards, D. A.; Mita, A. C.; Shagisultanova, E.; Osborne, C. R. C.; O'Shaughnessy, J.; Zhang, C.; Henner, R.; Kapoun, A. M.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Phase 1 study of the PSMA-targeted tubulysin small-molecule drug conjugate EC1169 in patients with metastatic castrate-resistant prostate cancer (mCRPC)

Meeting Abstract

Morris, M. J.; Petrylak, D. P.; Sartor, A. O.; Vogelzang, N. J.; Groaning, M.; Ejadi, S.; Tolcher, A. W.; Babiker, H. M.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Safety, pharmacokinetics and efficacy of IMCgp100, a first-in-class soluble TCR-antiCD3 bispecific t cell redirector with solid tumour activity: Results from the FIH study in melanoma

Meeting Abstract

Middleton, M. R.; Steven, N. M.; Evans, T. J.; Infante, J. R.; Sznol, M.; Mulatero, C.; Hamid, O.; Shoushtari, A. N.; Shingler, W.; Johnson, A.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Phase II study of the combination of bevacizumab plus irinotecan and temozolomide for relapsed or refractory neuroblastoma (NB)

Meeting Abstract

Modak, S.; Kushner, B. H.; Kramer, K.; Leyco, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K. V.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Evaluation of nurse practitioner-led survivorship care

Meeting Abstract

McCabe, M. S.; Boekhout, A. H.; Thom, B.; Corcoran, S.; Adsuar, R.; Oeffinger, K. C.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save